Treatment of DCIS—results from clinical trials
Author:
- 31 December 2003
- journal article
- review article
- Published by Elsevier in Surgical Oncology
- Vol. 12 (4) , 213-219
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breastThe American Journal of Surgery, 2003
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experienceSeminars in Oncology, 2001
- Risk Factors for Recurrence and Metastasis After Breast-Conserving Therapy for Ductal Carcinoma-In-Situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853Journal of Clinical Oncology, 2001
- Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrolAnti-Cancer Drugs, 2000
- Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853The Lancet, 2000
- Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trialThe Lancet, 1999
- Using Autopsy Series To Estimate the Disease “Reservoir” for Ductal Carcinoma in Situ of the Breast: How Much More Breast Cancer Can We Find?Annals of Internal Medicine, 1997
- Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)Cancer, 1995
- Follow-up of two treatment modalities for ductal cancer in situ of the breastBritish Journal of Surgery, 1989